Conditional survival for pediatric and adolescent patients with cancer: Implications for survivorship care

Cancer Epidemiology

Volumn 39, Issue 6, 2015, Pages 1071-1077

  Kaul, Sapna ^a   Kirchhoff, Anne C ^b   Boucher, Kenneth M ^c   Dietz, Andrew C ^d  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adolescent cancer; Conditional survival; Pediatric cancer

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE TUMOR; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; DATA BASE; EPITHELIUM TUMOR; FEMALE; GERM CELL TUMOR; GROUPS BY AGE; HUMAN; INFANT; KIDNEY TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NEWBORN; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOFT TISSUE SARCOMA; SURVIVAL TIME; UNITED STATES; ANXIETY; EPIDEMIOLOGY; MORTALITY; NEOPLASM; PROGNOSIS; RISK FACTOR; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ANXIETY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; NEUROBLASTOMA; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84951568456     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.09.006     Document Type: Article

References (39)

1. Ward E., DeSantis C., Robbins A., Kohler B., Jemal A. Childhood and adolescent cancer statistics, 2014. Cancer 2014, 64(2):83-103.
2. Robison L.L., Hudson M.M. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat. Rev. Cancer 2014, 14(1):61-70.
3. Baade P.D., Youlden D.R., Chambers S.K. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med. J. Aust. 2011, 194(2):73-77.
4. Parvez S., Abdel-Kader K., Song M.K., Unruh M. Conveying uncertainty in prognosis to patients with ESRD. Blood Purif. 2015, 39(1-3):58-64.
5. Weeks J.C., Cook E., O'Day S.J., et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998, 279(21):1709-1714.
6. Gustafson W.C., Matthay K.K. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma. Expert Rev. Neurother. 2011, 11(10):1411-1423.
7. Ward E., DeSantis C., Robbins A., Kohler B., Jemal A. Childhood and adolescent cancer statistics, 2014. Cancer 2014, 64(2):83-103.
8. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. Cancer 2008, 58(2):71-96.
9. Nathan P.C., Greenberg M.L., Ness K.K., Hudson M.M., Mertens A.C., Mahoney M.C., Gurney J.G., Donaldson S.S., Leisenring W.M., Robison L.L., Oeffinger K.C. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J. Clin. Oncol. 2008, 26(27):4401-4409.
10. Mertens A.C., Yong J., Dietz A.C., Kreiter E., Yasui Y., Bleyer A., Armstrong G.T., Robison L.L., Wasilewski-Masker K. Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program. Cancer 2014, 121(7):1108-1117.
11. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) Registries Research Data. (accessed June, 2015). http://seer.cancer.gov/data/metadata.html.
12. Kaul S., Barbeau B., Wright J., Fluchel M., Kirchhoff A.C., Nelson R.E. Statewide longitudinal hospital use and charges for pediatric and adolescent patients with cancer. J. Oncol. Pract. 2015, 10.1200/JOP.2014.003590.
13. Steliarova-Foucher E., Stiller C., Lacour B., Kaatsch P. International classification of childhood cancer, third edition. Cancer 2005, 103(7):1457-1467.
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53(282):457-481.
15. Davis F.G., McCarthy B.J., Freels S., Kupelian V., Bondy M.L. The conditional probability of survival of patients with primary malignant brain tumors. Cancer 1999, 85(2):485-491.
16. Smith M., Arthur D., Camitta B., Carroll A.J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E.L., Link M., Murphy S., Pui C.H., Pullen J., Reamon G., Sallan S.E., Sather H., Shuster J., Simon R., Trigg M., Tubergen D., Uckun F., Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 1996, 14(1):18-24.
17. Youlden D.R., Baade P.D., Hallahan A.R., Valery P.C., Green A.C., Aitken J.F. Conditional survival estimates for childhood cancer in Australia, 2002-2011: a population-based study. Cancer Epidemiol. 2015, 39(3):394-400.
18. Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., Friedman D.L., Marina N., Hobbie W., Kadan-Lottick N.S., Schwartz C.L., Leisenring W., Robison L.L. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 2006, 355(15):1572-1582.
19. Kaspers G.J. Pediatric acute myeloid leukemia. Expert Rev. Anticancer Ther. 2012, 12(3):405-413.
20. Rubnitz J.E., Inaba H. Childhood acute myeloid leukaemia. Br. J. Haematol. 2012, 159(3):259-276.
21. Luetke A., Meyers P.A., Lewis I., Juergens H. Osteosarcoma treatment-where do we stand? A state of the art review. Cancer Treatment Rev. 2014, 40(4):523-532.
22. Green D.M., Breslow N.E., Beckwith J.B., Finklestein J.Z., Grundy P., Thomas P.R., Kim T., Shochat S., Haase G., Ritchey M., Kelalis P., D'Angio G.J. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J. Clin. Oncol. 1998, 16(12):3744-3751.
23. Rivera G., Lugo-Vicente H. Thyroid cancer in children. Bol. Asoc. Med. P. R. 2014, 106(3):48-54.
24. Manola J., Atkins M., Ibrahim J., Kirkwood J. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials. J. Clin. Oncol. 2000, 18(22):3782-3793.
25. Kaatsch P., Häfner C., Calaminus G., Blettner M., Tulla M. Pediatric germ cell tumors from 1987 to 2011: incidence rates, time trends, and survival. Pediatrics 2015, 135(1):136-143.
26. Smith M., Arthur D., Camitta B., Carroll A.J., Crist W., Gaynon P., Gelber R., Heerema N., Korn E.L., Link M., Murphy S., Pui C.H., Pullen J., Reamon G., Sallan S.E., Sather H., Shuster J., Simon R., Trigg M., Tubergen D., Uckun F., Ungerleider R. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 1996, 14(1):18-24.
27. McDowell M.E., Occhipinti S., Ferguson M., Dunn J., Chambers S.K. Predictors of change in unmet supportive care needs in cancer. Psychooncology 2010, 19(5):508-516.
28. Hart S.L., Latini D.M., Cowan J.E., Carroll P.R. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support. Care Cancer 2008, 16(2):161-169.
29. Mertens A.C., Yong J., Dietz A.C., Kreiter E., Yasui Y., Bleyer A., Armstrong G.T., Robison L.L., Wasilewski-Masker K. Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program. Cancer 2015, 121(7):1108-1117.
30. Hudson S.V., Miller S.M., Hemler J., Ferrante J.M., Lyle J., Oeffinger K.C., Dipaola R.S. Adult cancer survivors discuss follow-up in primary care: 'not what i want, but maybe what i need'. Ann. Fam. Med. 2012, 10(5):418-427.
31. McCabe M.S., Partridge A.H., Grunfeld E., Hudson M.M. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin. Oncol. 2013, 40(6):804-812.
32. Kirchhoff A.C., Montenegro R.E., Warner E.L., Wright J., Fluchel M., Stroup A.M., Park E.R., Kinney A.Y. Childhood cancer survivors' primary care and follow-up experiences. Support. Care Cancer 2014, 22(6):1629-1653.
33. Burke R., Spoerri M., Price A., Cardosi A.M., Flanagan P. Survey of primary care pediatricians on the transition and transfer of adolescents to adult health care. Clin. Pediatr. 2008, 47(4):347-354.
34. Oeffinger K.C., Argenbright K.E., Levitt G.A., McCabe M.S., Anderson P.R., Berry E., Maher J., Merrill J., Wollins D.S. Models of cancer survivorship health care: moving forward. Am. Soc. Clin. Oncol. Educ. Book/ASCO Am. Soc. Clin. Oncol. Meeting 2014, 205-213.
35. Morgan M.A., Denlinger C.S. Survivorship tools for transitioning patients with cancer. J. Natl. Compr. Cancer Netw. JNCCN 2014, 12(12):1681-1687.
36. Mayer D.K., Gerstel A., Leak A.N., Smith S.K. Patient and provider preferences for survivorship care plans. J. Oncol. Pract./Am. Soc. Clin. Oncol. 2012, 8(4):80-86.
37. Shalom M.M., Hahn E.E., Casillas J., Ganz P.A. Do survivorship care plans make a difference? A primary care provider perspective. J. Oncol. Pract,/Am, Soc, Clin, Oncol 2011, 7(5):314-318.
38. Lee S.J., Storer B., Wang H., Lazarus H.M., Waller E.K., Isola L.M., Klumpp T.R., Umejiego J.B., Savani B.N., Loren A.W., Cairo M.S., Camitta B.M., Cutler C.S., George B., Jean K., houry H., Marks D.I., Rizzieri D.A., Copelan E.A., Gupta V., Liesveld J.L., Litzow M.R., Miller A.M., Schouten H.C., Gale R.P., Cahn J.Y., Weisdorf D.J. Providing personalized prognostic information for adult leukemia survivors. Biol. Blood Marrow Transplant. 2013, 19(11):1600-1607.
39. Rueth N.M., Groth S.S., Tuttle T.M., Virnig B.A., Al-Refaie W.B., Habermann E.B. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database. Ann. Surg. Oncol. 2010, 17(6):1662-1668.